Power Law company profile

Juno Therapeutics

Biotech & Life Sciences · Seattle, United States · Founded 2013 · IPO 2014 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$9.00B

Market cap · 2026

Revenue

$112M

Latest reported FY

Investors

4 investors on Juno Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

Bezos Expeditions

Venrock

Alaska Permanent Fund

ARCH Venture Partners

Global footprint

Where Juno Therapeutics has talent and traffic

Web traffic by country

710 monthly visits
across markets

🇺🇸 United States98.6%

Top 1 markets shown

Patent intelligence

$239M patent portfolio · 149 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$239M

2.7% of market cap · comparable to top peer Celularity ($195M)

149 active patent families

Where Juno Therapeutics innovates Cell biologyCell therapyBiophysicsCell sheetLymphocyte

Above peer median on Strategic, Market

Quality vs same-sector peers

Juno Therapeutics on the five Patsnap quality dimensions

Juno Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Juno Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Juno Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Juno Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo